Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
KMTS · against 437 other Healthcare companies of similar size
Ranked #314 of 438 · scores higher than 8% of peers
Bars: peers in each 10-point band of the valuation score125 peers with a valuation score of 0–9, including KMTS · Click a bar to see the companies
Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | KMTS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 427 reported | -9.2% | 1.7% | 17% | 30% | |
| EBITDA yieldHigher is better · 437 reported | -8.4% | 4.5% | 16% | 50% | |
| Free cash flow yieldHigher is better · 202 reported | -7.1% | -0.4% | 27% | 20% | |
| Book yieldHigher is better · 429 reported | 12.9% | 36.0% | 16% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 314 | 1.2B USD | 8 | 6 | |
| 314 | 3.1B USD | 8 | 39 | |
| 314 | 1.1B USD | 8 | 50 | |
| 314 | 927M USD | 8 | 41 | |
| 314 | 1.7B USD | 8 | 46 | |
| 314 | 879M USD | 8 | 36 | |
| 314 | 1.3B USD | 8 | 39 | |
| 314 | 1.8B USD | 8 | 42 | |
| 314 | 2.6B USD | 8 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score